HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Choto-san in the treatment of vascular dementia: a double-blind, placebo-controlled study.

Abstract
In an earlier placebo-controlled study, we demonstrated that a kampo (Japanese herbal) medicine called Choto-san (Diao-Teng-San in Chinese) was effective in treating vascular dementia. To evaluate its efficacy using more objective criteria, we carried out a multi-center, double-blind study of Choto-san extract (7.5 g/day) and a placebo, each given three times a day for 12 weeks to patients suffering from this condition. The study enrolled and analyzed 139 patients, 50 males and 89 females, with a mean age of 76.6 years. Choto-san was statistically superior to the placebo in global improvement rating, utility rating, global improvement rating of subjective symptoms, global improvement rating of psychiatric symptoms and global improvement rating of disturbance in daily living activities. Such items as spontaneity of conversation, lack of facial expression, decline in simple mathematical ability, global intellectual ability, nocturnal delirium, sleep disturbance, hallucination or delusion, and putting on and taking off clothes were significantly improved at one or more evaluation points in those taking Choto-san compared to those taking the placebo. Furthermore, the change in revised version of Hasegawa's dementia scale from the beginning point in Choto-san group was tended to be higher than that in placebo group with no statistical significance. These results suggest that Choto-san is effective in the treatment of vascular dementia.
AuthorsK Terasawa, Y Shimada, T Kita, T Yamamoto, H Tosa, N Tanaka, Y Saito, E Kanaki, S Goto, N Mizushima, M Fujioka, S Takase, H Seki, I Kimura, T Ogawa, S Nakamura, G Araki, I Maruyama, Y Maruyama, S Takaori
JournalPhytomedicine : international journal of phytotherapy and phytopharmacology (Phytomedicine) Vol. 4 Issue 1 Pg. 15-22 (Mar 1997) ISSN: 0944-7113 [Print] Germany
PMID23195240 (Publication Type: Journal Article)
CopyrightCopyright © 1997 Gustav Fischer Verlag. Published by Elsevier GmbH.. All rights reserved.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: